KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Teva Pharmaceutical Industries (TEVA) Invested Capital: 2009-2024

Historic Invested Capital for Teva Pharmaceutical Industries (TEVA) over the last 16 years, with Dec 2024 value amounting to $7.2 billion.

  • Teva Pharmaceutical Industries' Invested Capital fell 18.80% to $7.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $7.3 billion, marking a year-over-year decrease of 18.80%. This contributed to the annual value of $7.2 billion for FY2024, which is 26.91% down from last year.
  • Per Teva Pharmaceutical Industries' latest filing, its Invested Capital stood at $7.2 billion for FY2024, which was down 26.91% from $9.8 billion recorded in FY2023.
  • Teva Pharmaceutical Industries' 5-year Invested Capital high stood at $14.2 billion for FY2020, and its period low was $7.2 billion during FY2024.
  • For the 3-year period, Teva Pharmaceutical Industries' Invested Capital averaged around $9.2 billion, with its median value being $9.8 billion (2023).
  • Data for Teva Pharmaceutical Industries' Invested Capital shows a maximum YoY dropped of 26.91% (in 2024) over the last 5 years.
  • Yearly analysis of 5 years shows Teva Pharmaceutical Industries' Invested Capital stood at $14.2 billion in 2020, then decreased by 11.08% to $12.7 billion in 2021, then fell by 15.49% to $10.7 billion in 2022, then decreased by 8.49% to $9.8 billion in 2023, then dropped by 26.91% to $7.2 billion in 2024.